中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
23期
17-21
,共5页
叶振海%于芝%叶青山%曹相原
葉振海%于芝%葉青山%曹相原
협진해%우지%협청산%조상원
早发性呼吸机相关肺炎%晚发性呼吸机相关肺炎%危险因素%病原菌
早髮性呼吸機相關肺炎%晚髮性呼吸機相關肺炎%危險因素%病原菌
조발성호흡궤상관폐염%만발성호흡궤상관폐염%위험인소%병원균
Early-onset ventilator-associated pneumonia%Late-onset ventilator-associated pneumonia%Risk factors%Pathogens
目的:通过对有创机械通气时间超过48h患者的临床资料进行回顾性分析,比较早发性和晚发性VAP相关危险因素、发生率、病死率以及病原菌流行病学特点,为防治VAP提供科学依据。方法回顾性分析2008年5月~2011年9月间在我院ICU科住院治疗的183例VAP患者的临床资料,将VAP患者分为早发性VAP(EOP)组和晚发性VAP(LOP)组。观察比较两组患者相关危险因素;对两组患者的微生物学资料进行调查。结果EOP和LOP的发生率分别为26.78%和73.22%,病死率分别为20.41%和41.04%。GCS评分6~9分时LOP多见,在10~14分时EOP多见。住院时间<7d时间段内EOP患者多于LOP患者;住院时间>14d时间段LOP患者多于EOP患者(P<0.05)。G-菌的构成比在LOP组及EOP组中均占优势。嗜麦芽寡养单胞菌多见于LOP,肺炎克雷伯氏菌多见于EOP。≥2种病原菌混合感染及合并真菌感染LOP患者多于EOP患者(P<0.05)。结论尽量避免VAP相关危险因素,早期诊断、早期治疗,对降低VAP的发病率和病死率具有重要意义。
目的:通過對有創機械通氣時間超過48h患者的臨床資料進行迴顧性分析,比較早髮性和晚髮性VAP相關危險因素、髮生率、病死率以及病原菌流行病學特點,為防治VAP提供科學依據。方法迴顧性分析2008年5月~2011年9月間在我院ICU科住院治療的183例VAP患者的臨床資料,將VAP患者分為早髮性VAP(EOP)組和晚髮性VAP(LOP)組。觀察比較兩組患者相關危險因素;對兩組患者的微生物學資料進行調查。結果EOP和LOP的髮生率分彆為26.78%和73.22%,病死率分彆為20.41%和41.04%。GCS評分6~9分時LOP多見,在10~14分時EOP多見。住院時間<7d時間段內EOP患者多于LOP患者;住院時間>14d時間段LOP患者多于EOP患者(P<0.05)。G-菌的構成比在LOP組及EOP組中均佔優勢。嗜麥芽寡養單胞菌多見于LOP,肺炎剋雷伯氏菌多見于EOP。≥2種病原菌混閤感染及閤併真菌感染LOP患者多于EOP患者(P<0.05)。結論儘量避免VAP相關危險因素,早期診斷、早期治療,對降低VAP的髮病率和病死率具有重要意義。
목적:통과대유창궤계통기시간초과48h환자적림상자료진행회고성분석,비교조발성화만발성VAP상관위험인소、발생솔、병사솔이급병원균류행병학특점,위방치VAP제공과학의거。방법회고성분석2008년5월~2011년9월간재아원ICU과주원치료적183례VAP환자적림상자료,장VAP환자분위조발성VAP(EOP)조화만발성VAP(LOP)조。관찰비교량조환자상관위험인소;대량조환자적미생물학자료진행조사。결과EOP화LOP적발생솔분별위26.78%화73.22%,병사솔분별위20.41%화41.04%。GCS평분6~9분시LOP다견,재10~14분시EOP다견。주원시간<7d시간단내EOP환자다우LOP환자;주원시간>14d시간단LOP환자다우EOP환자(P<0.05)。G-균적구성비재LOP조급EOP조중균점우세。기맥아과양단포균다견우LOP,폐염극뢰백씨균다견우EOP。≥2충병원균혼합감염급합병진균감염LOP환자다우EOP환자(P<0.05)。결론진량피면VAP상관위험인소,조기진단、조기치료,대강저VAP적발병솔화병사솔구유중요의의。
Objective To retrospectively analyze clinical data of patient in invasive mechanical ventilation more than 48 hours and compared early-onset and late-onset VAP-related risk factors, incidence, mortality and epidemiological characteristics of pathogens, to provide scientific basis for combating VAP. Methods A clinical data of 183 cases of patients with VAP treated in ICU department our hospital from May 2008 to September 2011 was retrospective analyzed and divided into early-onset VAP (EOP) and late-onset VAP group (LOP) group. Two groups of patients with associated risk factors were observed and compard; and both groups of patients microbiology data were investigated. Results Incidence of EOP and LOP were 26.78%and 73.22%,respectively, mortality were 20.41%and 41.04%. LOP was more common with GCS score 6-9, shared EOP common with GOS score 10 to 14. less than 7 days period in hospitalization EOP was more than LOP in patients;longer than 14 days time period in hospitalization LOP was more than EOP in patients (P < 0.05). Constituent ratio of G- bacteria was competitive in both LOP and EOP group. Stenotrophomonas maltophilia was prevalent in the LOP, Klebsiella pneumoniae was prevalent in the EOP. LOP with more than 2 kinds of mixed infection and fungal infection was more than EOP (P<0.05). Conclusion To avoid VAP-related risk factors, early diagnosis, early treatment, to reduce the incidence and mortality of VAP will be great of significance.